Search
for

    Research 10 of 1000+

    1. Psychiatric and sexual dysfunction warnings strengthened for finasteride and dutasteride 2026
    2. Post-finasteride syndrome: pharmacists must lead the conversation on patient safety 2026
    3. The combination of ethinylestradiol/cyproterone acetate is temporarily withdrawn from the market in France. Is the measure justified? The European Journal of Contraception & Reproductive Health Care · 2013 · 1 citations
    4. Depression, suicidal thoughts with finasteride (Propecia) Reactions Weekly · 2017
    5. Finasteride drug safety alert Drug and Therapeutics Bulletin · 2017
    6. Safety update: psychiatric and sexual adverse effects with finasteride Drug and therapeutics bulletin · 2024
    7. This sector needs laser protection supervisors Journal of Aesthetic Nursing · 2018
    8. Current Status of PRP Manufacturing Requirements & European Regulatory Frameworks: Practical Tools for the Appropriate Implementation of PRP Therapies in Musculoskeletal Regenerative Medicine Bioengineering · 2023 · 21 citations
    9. Marketing Experimental Stem Cell Therapies in the UK: Biomedical Lifestyle Products and the Promise of Regenerative Medicine in the Digital Era Science as Culture · 2019 · 15 citations
    10. Comparative Analysis of Labeling and Claim Substantiation Requirements for Herbal Hair Products across Different Regulatory Jurisdictions International Journal of Newgen Research in Pharmacy & Healthcare · 2025
    All research results →

    Learn 1 of 28

    1. Finasteride Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically
    All learn results →

    Community

    — no results

    Try a deeper search in community →